Cetirizine Hydrochloride Tablets · CETIRIZINE HYDROCHLORIDE 10 mg/1 · Tablet, Film Coated · Oral · Strategic Sourcing Services LLC
NDC 70677-1007-02 · 1 BOTTLE in 1 CARTON / 60 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
8 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.0629 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | CETIRIZINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Northwind Health Company, LLC | CETIRIZINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. | CETIRIZINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | CETIRIZINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sportpharm LLC | CETIRIZINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Verityrx, Llc | CETIRIZINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc. | CETIRIZINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Strategic Sourcing Services LLC | CETIRIZINE HYDROCHLORIDE 10 mg/1 | Jul 15, 2026 | Aug 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "cetirizine hydrochloride — NDC 70677-1007-02," retrieved September 3, 2026, https://drugdashboards.com/drug/70677100702.
Free to cite with attribution — see how the data is put together.